{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:05:59Z","timestamp":1792641959469,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T00:00:00Z","timestamp":1687910400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.breast.2023.06.011","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T08:42:00Z","timestamp":1688978520000},"page":"89-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["This house believes that: MARI\/TAD is better than sentinel node biopsy after PST for cN+ patients"],"prefix":"10.1016","volume":"71","author":[{"given":"Annemiek K.E.","family":"van Hemert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederieke H.","family":"van Duijnhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4472-4257","authenticated-orcid":false,"given":"Marie-Jeanne T.F.D.","family":"Vrancken Peeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 3","key":"10.1016\/j.breast.2023.06.011_bib1","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1245\/s10434-018-7046-9","article-title":"ASO author reflections: changes in use of neoadjuvant chemotherapy over time-highest rates of use now in triple-negative and HER2+ disease","volume":"25","author":"Murphy","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.breast.2023.06.011_bib2","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1245\/s10434-013-2909-6","article-title":"Breast-conserving surgery after tumor downstaging by neoadjuvant chemotherapy is oncologically safe for stage III breast cancer patients","volume":"20","author":"Shin","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.breast.2023.06.011_bib3","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/bjs.5894","article-title":"Neoadjuvant chemotherapy for operable breast cancer","volume":"94","author":"Mieog","year":"2007","journal-title":"Br J Surg"},{"issue":"29","key":"10.1016\/j.breast.2023.06.011_bib4","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1200\/JCO.2012.45.0940","article-title":"Response-guided neoadjuvant chemotherapy for breast cancer","volume":"31","author":"von Minckwitz","year":"2013","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.breast.2023.06.011_bib5","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1001\/jamaoncol.2016.4163","article-title":"Axillary nodal management following neoadjuvant chemotherapy: a review","volume":"3","author":"Pilewskie","year":"2017","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1016\/j.breast.2023.06.011_bib6","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s10549-020-05966-y","article-title":"Disease-free and overall survival after neoadjuvant chemotherapy in breast cancer: breast-conserving surgery compared to mastectomy in a large single-centre cohort study","volume":"185","author":"Simons","year":"2021","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.breast.2023.06.011_bib7","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejso.2018.09.027","article-title":"Breast conserving therapy after neoadjuvant chemotherapy; data from the Dutch Breast Cancer Audit","volume":"45","author":"Spronk","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"10.1016\/j.breast.2023.06.011_bib8","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jamcollsurg.2015.02.011","article-title":"Neoadjuvant chemotherapy for breast cancer increases the rate of breast conservation: results from the National Cancer Database","volume":"220","author":"Killelea","year":"2015","journal-title":"J Am Coll Surg"},{"issue":"5","key":"10.1016\/j.breast.2023.06.011_bib9","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1245\/s10434-016-5733-y","article-title":"National Trends in the use of neoadjuvant chemotherapy for hormone receptor-negative breast cancer: a national cancer data Base study","volume":"24","author":"Puig","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.breast.2023.06.011_bib10","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1245\/s10434-018-6531-5","article-title":"Neoadjuvant chemotherapy use in breast cancer is greatest in excellent Responders: triple-negative and HER2+ subtypes","volume":"25","author":"Murphy","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.breast.2023.06.011_bib11","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/bjs\/znac217","article-title":"Axillary surgery after neoadjuvant therapy in initially node-positive breast cancer: international EUBREAST survey","volume":"109","author":"Gasparri","year":"2022","journal-title":"Br J Surg"},{"issue":"22","key":"10.1016\/j.breast.2023.06.011_bib12","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1056\/NEJMoa1612645","article-title":"Adjuvant capecitabine for breast cancer after preoperative chemotherapy","volume":"376","author":"Masuda","year":"2017","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.breast.2023.06.011_bib13","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa1814017","article-title":"Trastuzumab emtansine for residual invasive HER2-positive breast cancer","volume":"380","author":"von Minckwitz","year":"2019","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.breast.2023.06.011_bib14","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1001\/jamaoncol.2021.1371","article-title":"Three-year follow-up of neoadjuvant chemotherapy with or without Anthracyclines in the presence of dual ERBB2 Blockade in patients with ERBB2-positive breast cancer: a secondary analysis of the TRAIN-2 Randomized, phase 3 trial","volume":"7","author":"van der Voort","year":"2021","journal-title":"JAMA Oncol"},{"issue":"5","key":"10.1016\/j.breast.2023.06.011_bib15","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.2214\/AJR.05.0936","article-title":"Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: a systematic review","volume":"186","author":"Alvarez","year":"2006","journal-title":"AJR Am J Roentgenol"},{"issue":"30","key":"10.1016\/j.breast.2023.06.011_bib16","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1200\/JCO.2014.57.8401","article-title":"Axillary ultrasound after neoadjuvant chemotherapy and its impact on sentinel lymph node surgery: results from the American College of Surgeons oncology group Z1071 trial (alliance)","volume":"33","author":"Boughey","year":"2015","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.breast.2023.06.011_bib17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10549-011-1767-9","article-title":"18F-FDG PET\/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques","volume":"131","author":"Koolen","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.breast.2023.06.011_bib18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10549-012-2179-1","article-title":"Locoregional lymph node involvement on 18F-FDG PET\/CT in breast cancer patients scheduled for neoadjuvant chemotherapy","volume":"135","author":"Koolen","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"10.1016\/j.breast.2023.06.011_bib19","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1245\/s10434-010-0934-2","article-title":"Can breast MRI predict axillary lymph node metastasis in women undergoing neoadjuvant chemotherapy","volume":"17","author":"Javid","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.breast.2023.06.011_bib20","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archsurg.1992.01420040034005","article-title":"Technical details of intraoperative lymphatic mapping for early stage melanoma","volume":"127","author":"Morton","year":"1992","journal-title":"Arch Surg"},{"issue":"6","key":"10.1016\/j.breast.2023.06.011_bib21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0960-7404(93)90064-6","article-title":"Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe","volume":"2","author":"Krag","year":"1993","journal-title":"Surg Oncol"},{"issue":"4","key":"10.1016\/j.breast.2023.06.011_bib22","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/jso.20866","article-title":"Sentinel lymph node biopsy for breast cancer","volume":"96","author":"Sato","year":"2007","journal-title":"J Surg Oncol"},{"issue":"2","key":"10.1016\/j.breast.2023.06.011_bib23","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/SLA.0000000000000558","article-title":"Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure","volume":"261","author":"Donker","year":"2015","journal-title":"Ann Surg"},{"issue":"11","key":"10.1016\/j.breast.2023.06.011_bib24","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/jamasurg.2022.3907","article-title":"Diagnostic accuracy of radioactive iodine seed Placement in the axilla with sentinel lymph node biopsy after neoadjuvant chemotherapy in node-positive breast cancer","volume":"157","author":"Simons","year":"2022","journal-title":"JAMA Surg"},{"issue":"10","key":"10.1016\/j.breast.2023.06.011_bib25","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","article-title":"Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection","volume":"34","author":"Caudle","year":"2016","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.breast.2023.06.011_bib26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/jamasurg.2014.1086","article-title":"Selective surgical localization of axillary lymph nodes containing metastases in patients with breast cancer: a prospective feasibility trial","volume":"150","author":"Caudle","year":"2015","journal-title":"JAMA Surg"},{"issue":"5","key":"10.1016\/j.breast.2023.06.011_bib27","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.clbc.2017.04.006","volume":"17","author":"van Nijnatten","year":"2017","journal-title":"Clin Breast Cancer"},{"issue":"2","key":"10.1016\/j.breast.2023.06.011_bib28","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1200\/JCO.2007.11.5352","article-title":"Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy","volume":"26","author":"Jeruss","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2023.06.011_bib29","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ejca.2017.04.012","article-title":"Factors predictive of locoregional recurrence following neoadjuvant chemotherapy in patients with large operable or locally advanced breast cancer: an analysis of the EORTC 10994\/BIG 1-00 study","volume":"79","author":"Gillon","year":"2017","journal-title":"Eur J Cancer"},{"issue":"32","key":"10.1016\/j.breast.2023.06.011_bib30","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1200\/JCO.2011.40.8369","article-title":"Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27","volume":"30","author":"Mamounas","year":"2012","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.breast.2023.06.011_bib31","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/cncr.10786","article-title":"Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma","volume":"95","author":"Krishnamurthy","year":"2002","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.breast.2023.06.011_bib32","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1016\/j.ejrad.2016.10.030","article-title":"Routine use of standard breast MRI compared to axillary ultrasound for differentiating between no, limited and advanced axillary nodal disease in newly diagnosed breast cancer patients","volume":"85","author":"van Nijnatten","year":"2016","journal-title":"Eur J Radiol"},{"issue":"29","key":"10.1016\/j.breast.2023.06.011_bib33","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.1200\/JCO.2008.17.1496","article-title":"Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography\/computed tomography compared with conventional imaging procedures","volume":"26","author":"Fuster","year":"2008","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.breast.2023.06.011_bib34","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1148\/radiol.12110853","article-title":"Performance of FDG PET\/CT in the clinical management of breast cancer","volume":"266","author":"Groheux","year":"2013","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.breast.2023.06.011_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-54017-0","article-title":"Diagnostic performance of axillary ultrasound and standard breast MRI for differentiation between limited and advanced axillary nodal disease in clinically node-positive breast cancer patients","volume":"9","author":"Samiei","year":"2019","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.breast.2023.06.011_bib36","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1148\/radiology.203.2.9114082","article-title":"Axillary lymph node metastases: screening with [F-18]2-deoxy-2-fluoro-D-glucose (FDG) PET","volume":"203","author":"Adler","year":"1997","journal-title":"Radiology"},{"key":"10.1016\/j.breast.2023.06.011_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jval.2015.09.123","article-title":"MD4\u2014cost-effectiveness of 18f-Fdg Pet\/Ct for screening distant metastasis in stage Ii\/Iii breast cancer patients of the UK, the United States and The Netherlands","author":"Miquel-Cases","year":"2015","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.breast.2023.06.011_bib38","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/SLA.0000000000004356","article-title":"Diagnostic performance of noninvasive imaging for assessment of axillary response after neoadjuvant systemic therapy in clinically node-positive breast cancer: a systematic review and meta-analysis","volume":"273","author":"Samiei","year":"2021","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.breast.2023.06.011_bib39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejrad.2014.09.020","article-title":"Noninvasive nodal restaging in clinically node positive breast cancer patients after neoadjuvant systemic therapy: a systematic review","volume":"84","author":"Schipper","year":"2015","journal-title":"Eur J Radiol"},{"issue":"7","key":"10.1016\/j.breast.2023.06.011_bib40","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol"},{"issue":"14","key":"10.1016\/j.breast.2023.06.011_bib41","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.breast.2023.06.011_bib42","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10549-017-4164-1","article-title":"Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer","volume":"163","author":"Zetterlund","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"13","key":"10.1016\/j.breast.2023.06.011_bib43","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1245\/s10434-019-07809-7","article-title":"Axillary lymph node ultrasound following neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: results from the SN FNAC study","volume":"26","author":"Morency","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.breast.2023.06.011_bib44","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10549-018-5004-7","article-title":"Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study","volume":"173","author":"Classe","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"10.1016\/j.breast.2023.06.011_bib45","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1245\/s10434-010-1155-4","article-title":"Morbidity of sentinel node biopsy in breast cancer: the relationship between the number of excised lymph nodes and lymphedema","volume":"17","author":"Goldberg","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.breast.2023.06.011_bib46","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4048\/jbc.2021.24.e9","article-title":"Association between number of Retrieved sentinel lymph nodes and breast cancer-related lymphedema","volume":"24","author":"Kim","year":"2021","journal-title":"J Breast Cancer"},{"issue":"10","key":"10.1016\/j.breast.2023.06.011_bib47","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1245\/s10434-011-1688-1","article-title":"Morbidity of sentinel node biopsy: relationship between number of excised lymph nodes and patient perceptions of lymphedema","volume":"18","author":"Goldberg","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.breast.2023.06.011_bib48","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s10549-022-06588-2","article-title":"False-negative rate in the extended prospective TATTOO trial evaluating targeted axillary dissection by carbon tattooing in clinically node-positive breast cancer patients receiving neoadjuvant systemic therapy","volume":"193","author":"de Boniface","year":"2022","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"10.1016\/j.breast.2023.06.011_bib49","doi-asserted-by":"crossref","first-page":"e553","DOI":"10.1097\/SLA.0000000000004572","article-title":"A prospective, multicenter Registry study to evaluate the clinical feasibility of targeted axillary dissection (TAD) in node-positive breast cancer patients","volume":"276","author":"Kuemmel","year":"2022","journal-title":"Ann Surg"},{"issue":"11","key":"10.1016\/j.breast.2023.06.011_bib50","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1245\/s10434-018-6548-9","article-title":"Intraoperative touch imprint cytology in targeted axillary dissection after neoadjuvant chemotherapy for breast cancer patients with initial axillary metastasis","volume":"25","author":"Wu","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.breast.2023.06.011_bib51","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1245\/s10434-017-6270-z","article-title":"Intraoperative ultrasound-guided excision of axillary clip in patients with node-positive breast cancer treated with neoadjuvant therapy (ILINA trial) : a New tool to Guide the excision of the clipped node after neoadjuvant treatment","volume":"25","author":"Siso","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.breast.2023.06.011_bib52","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10549-022-06545-z","article-title":"Three-year follow-up of de-escalated axillary treatment after neoadjuvant systemic therapy in clinically node-positive breast cancer: the MARI-protocol","volume":"193","author":"van Loevezijn","year":"2022","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"10.1016\/j.breast.2023.06.011_bib53","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ejso.2020.10.014","article-title":"Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up","volume":"47","author":"Kahler-Ribeiro-Fontana","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10.1016\/j.breast.2023.06.011_bib54","doi-asserted-by":"crossref","first-page":"e544","DOI":"10.1097\/SLA.0000000000004562","article-title":"Sentinel node biopsy alone or with axillary dissection in breast cancer patients after primary chemotherapy: long-term results of a prospective interventional study","volume":"276","author":"Martelli","year":"2022","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.breast.2023.06.011_bib55","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1245\/s10434-020-09211-0","article-title":"Oncologic safety of sentinel lymph node biopsy alone after neoadjuvant chemotherapy for breast cancer","volume":"28","author":"Wong","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.breast.2023.06.011_bib56","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1001\/jamaoncol.2021.4394","article-title":"Nodal recurrence in patients with node-positive breast cancer treated with sentinel node biopsy alone after neoadjuvant chemotherapy-A Rare event","volume":"7","author":"Barrio","year":"2021","journal-title":"JAMA Oncol"},{"issue":"12","key":"10.1016\/j.breast.2023.06.011_bib57","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1245\/s10434-020-08900-0","article-title":"Oncologic outcomes of sentinel lymph node surgery after neoadjuvant chemotherapy for node-positive breast cancer","volume":"27","author":"Piltin","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2023.06.011_bib58","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.breast.2021.09.004","article-title":"Tailored axillary surgery in patients with clinically node-positive breast cancer: pre-planned feasibility substudy of TAXIS (OPBC-03, SAKK 23\/16, IBCSG 57-18, ABCSG-53, GBG 101)","volume":"60","author":"Weber","year":"2021","journal-title":"Breast"},{"key":"10.1016\/j.breast.2023.06.011_bib59","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.breast.2022.12.010","article-title":"This house believes that: sentinel node biopsy alone is better than TAD after NACT for cN+ patients","volume":"67","author":"Galimberti","year":"2023","journal-title":"Breast"},{"issue":"6","key":"10.1016\/j.breast.2023.06.011_bib60","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2021.0891","article-title":"Axillary pathologic complete response after neoadjuvant systemic therapy by breast cancer subtype in patients with initially clinically node-positive disease: a systematic review and meta-analysis","volume":"156","author":"Samiei","year":"2021","journal-title":"JAMA Surg"},{"issue":"9935","key":"10.1016\/j.breast.2023.06.011_bib61","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(14)60488-8","article-title":"Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials","volume":"383","author":"Ebctcg","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.breast.2023.06.011_bib62","article-title":"Abstract GS4-02: oncological outcomes following omission of axillary lymph node dissection in node positive patients downstaging to node negative with neoadjuvant chemotherapy: the OPBC-04\/EUBREAST-06\/OMA study","volume":"83","author":"Giacomo Montagna","year":"2023","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.breast.2023.06.011_bib63","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/bjs.10555","article-title":"Combined PET-CT and axillary lymph node marking with radioactive iodine seeds (MARI procedure) for tailored axillary treatment in node-positive breast cancer after neoadjuvant therapy","volume":"104","author":"Koolen","year":"2017","journal-title":"Br J Surg"},{"key":"10.1016\/j.breast.2023.06.011_bib64","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.SABCS17-OT2-03-02","volume":"78","author":"Mamounas Hb","year":"2018","journal-title":"Cancer Res"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977623005155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977623005155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:47:35Z","timestamp":1760777255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977623005155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":64,"alternative-id":["S0960977623005155"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2023.06.011","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"This house believes that: MARI\/TAD is better than sentinel node biopsy after PST for cN+ patients","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2023.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}